Puri Michal Nath

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Puri Michal Nath's trades of NovoCure Limited's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
111.11
Quantity 85,051 +34.1%
Value US$1,531,996
Transaction date
Sale
Price
145.80
Quantity 54,773 +15.8%
Value US$1,510,679
Transaction date
Sale
Price
422.69
Quantity 36,991 -14.6%
Value US$3,785,078
Transaction date
Sale
Price
20.55
Quantity 225 -0.2%
Value US$4,624
Transaction date
Sale
Price
19.92
Quantity 1,162 -1.1%
Value US$23,149
Transaction date
Sale
Price
15.79
Quantity 810 -0.7%
Value US$12,792
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-04 2026-11-02
S Sale
85,051 +34.1%
111.11
US$1,531,996 		85,051 +34.1% 111.11 US$1,531,996
2026-03-05 2026-03-04
S Sale
54,773 +15.8%
145.80
US$1,510,679 		54,773 +15.8% 145.80 US$1,510,679
2026-03-03 2026-02-27
S Sale
36,991 -14.6%
422.69
US$3,785,078 		36,991 -14.6% 422.69 US$3,785,078
2025-03-03 2025-02-27
S Sale
225 -0.2%
20.55
US$4,624 		225 -0.2% 20.55 US$4,624
2025-03-03 2025-02-27
S Sale
1,162 -1.1%
19.92
US$23,149 		1,162 -1.1% 19.92 US$23,149
2024-11-04 2024-10-31
S Sale
810 -0.7%
15.79
US$12,792 		810 -0.7% 15.79 US$12,792